School of Pharmacy

NewsEventsApply NowMake a Gift

News

three representatives from the v.c.u. school of pharmacy hold up a signed agreement while representatives from taipei medical university hold up a signed agreement on a video feed displayed on a large screen

VCU School of Pharmacy announces partnership with Taipei Medical University

Dec. 1, 2023

VCU School of Pharmacy and Taipei Medical University in Taiwan have signed a memorandum of understanding that confirms the intention of the institutions to develop collaborative activities in academics and research.

A new VCU-led study is among the first to explore the economics of pharmacist prescribing to improve blood pressure control.(Getty Images)

Expanding pharmacists’ role for patients with hypertension could prevent 15 million heart attacks and save $1.1 trillion over 30 years, VCU-led study finds

Nov. 3, 2023

The study details how pharmacists’ ability to treat patients with hypertension could have a positive impact on both Americans’ quality of life and the U.S. health care system.

A new award, which will be given annually, honors VCU faculty members who were nationally or internationally recognized for exceptional accomplishments during the course of their current evaluation period. (Enterprise Marketing and Communications)

VCU announces first class of faculty scholars honored for ‘exceptional accomplishments’

Oct. 11, 2023

National/International Recognition Award will reward faculty members who personify the uncommon excellence that can be found across VCU.

VCU Alumni 10 Under 10 award recipients to be honored for noteworthy achievements

Sept. 27, 2023

Distinguished graduates from throughout the university will be recognized at a private ceremony Oct. 21.

(From left to right) Curtis N. Sessler, M.D., School of Medicine; Anika L. Hines, Ph.D., School of Medicine, School of Population Health; Deborah L. Polo, College of Humanities and Sciences; Fotis Sotiropoulos, Ph.D., provost and senior vice president for academic affairs; VCU President Michael Rao, Ph.D.; Emiola Oyefuga, Ph.D., School of Education; Martin K. Safo, Ph.D., School of Pharmacy; Evan M. Sisson, Pharm.D., School of Pharmacy; and Michael F. Miles, M.D., Ph.D., School of Medicine. (Tom Kojcsich, Enterprise Marketing and Communications)

Excellence – and commitment – celebrated at VCU Faculty Convocation

Sept. 7, 2023

Seven educators and researchers are highlighted at 41st annual ceremony, where President Michael Rao links education and empathy.

Faculty Convocation will honor seven VCU educators and researchers for excellence

Aug. 31, 2023

Annual ceremony on Sept. 6 highlights teaching, scholarship and service.

Rebecca Martin, Ph.D., a professor in the School of Medicine, is a co-founder of Pleros Therapeutics. Its leading product is a molecule drug that targets enzymes involved in allergy responses, specifically asthma. (Kevin Morley, Enterprise Marketing and Communications)

More than ever, startups at VCU are turning ideas into businesses

July 11, 2023

Where science meets commerce, TechTransfer and Ventures is helping inventors find an audience beyond campus.

The Blick Scholar award is a premier recognition for those junior faculty members who have been exceptionally successful in research. (File photo)

Five new Blick Scholars reflect how VCU junior faculty are making their mark in medical research

June 20, 2023

From longevity and neuroscience to asthma and health equity, these assistant professors are rising stars in their fields.

Rachael Flammia works with Yan Zhang, Ph.D., in his lab. Zhang is studying the development of a means to reverse the acute and chronic toxicity of fentanyl, a synthetic opioid that is 30 times more potent than heroin and 100 times more potent than morphine. (Photo: Tyler Trumbo, MCV Foundation)

Fighting fentanyl

May 17, 2023

VCU researchers are spearheading efforts to reverse the toxicity of the potent synthetic.

A VCU-led study has identified DNA markers already present in newborns that were associated with an increased risk of developing schizophrenia. (Getty Images)

DNA methylation markers for increased risk of schizophrenia identified for first time in newborns

May 15, 2023

Research will continue to develop potential future clinical biomarkers that will allow early detection and intervention, according to one of the VCU investigators who led the research team.